Carribean Puerto Rico Papua New Guinea and American Samoa Geography Timing Signs and Symptoms Classic Features 312 days Conjunctivitis arthralgia rash or fever Mimics dengue chikungunya ID: 775240
Download Presentation The PPT/PDF document " Zika Zika Central/South America" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Zika
Slide2Zika
Central/South America
Carribean
, Puerto Rico
Papua New Guinea and American Samoa
Geography
Timing
Signs and Symptoms
Classic Features
3-12 days
Conjunctivitis, arthralgia, rash, or fever
Mimics dengue, chikungunya
Conjunctivitis
Microcephaly due to congenital infection
Slide3Zika
Arbovirus, genus
Flavivirus
Related to dengue, yellow fever, West Nile virus
Only 1 in 5 infections are symptomatic
Symptoms usually mild, lasting up to a week
Before 2015, reported in Africa, SE Asia, Pacific Islands
Guillain-Barré
reported following
Zika
infection
Slide4Zika
2015 Brazil outbreak associated with increase in babies born with microcephaly
Transmission routes now known:
From mosquito bite
In utero mother to fetus
Sexual transmission from male partner
Blood transfusion
Slide5Zika: Q and A
Where is Zika?
Evaluation of Congenital Zika
What is a positive Zika test?
Where is Zika in the US?
Testing for Congenital Zika
Guillain-Barré Syndrome
Breastfeeding
How do I test for acute Zika?
When do I test for acute Zika?
Long term follow-up of Congenital Zika
Guidance for Travel
Sexual Transmission
Slide6Where is Zika?
http://www.cdc.gov/zika/geo/index.html
, May 26th
Slide7What about the US?
Active transmission in Puerto Rico, US Virgin Islands, American Samoa
935 cases, 142 pregnant women591 US travel-associated cases168 pregnant women11 sexually transmitted1 with Guillain-Barré
Slide8What is a positive Zika test?
Zika virus RNA on reverse transcriptase-PCRZika virus IgM with neutralizing antibody titers >= 4 times higher than dengue virus neutralizing antibody titersIf antibody titers <4x higher, test is considered inconclusiveRT-PCR may be negative after in utero infectionFalse positive IgM due to dengue and yellow fever
Slide9When to Test for Acute Zika
Patients with travel to an affected area within 2 weeks and 2 or more of the followingFever, rash, conjunctivitis, or arthralgiaInfants under 2 weeks if mother travelled to an affected area within 2 weeks of delivery and the infant has 2 or more of above symptoms
Slide10How to Test for Acute Zika
Serum RT-PCR within 7 days of symptomsUrine RT-PCR within 14 days of symptomsIgM serology and neutralizing antibodies >4 days of symptomsCSF can be tested for Zika virus RNA if clinical concern
Slide11Figure 6:
CDC testing algorithm for Chikungunya, Dengue &
Zika
virus
Slide12Guillain-Barré Syndrome
Zika virus infection associated with increased rates of GBSCausal relationship not yet establishedRisk increases with increasing age
Slide13Testing for Congenital Zika
Infants with microcephaly or intracranial calcifications and a positive maternal travel history should be tested within 48 hours of birthInfants without those abnormalities should be tested if the mother had positive or inconclusive Zika serum testsInfants without abnormalities do not need to be tested if the mother was negative or had travel but no testingRT-PCR and IgM should both be sentPlacenta and umbilical cord tissue can also be tested
Slide14Slide15Evaluation of Congenital Zika
Physical examinationHead circumference, length, weight, gestational ageNeurologic examDysmorphic featuresHepatosplenomegalyRashCranial ultrasound if not documented as normal in third trimesterOphthalmology examNewborn hearing screenIf abnormalities, consider genetics, neurology & ID
Slide16Congenital Neurologic Abnormalities
Microcephaly with intracranial calcifications, ventriculomegaly, lissencephaly, pachygyriaFetal Brain Disruption SyndromeCongenital contractures, clubfootAbnormal eye findings
Slide17Zika's ground zero: Generation of babies born with microcephaly face uncertain future
Slide18Long-term Follow-Up
Infants with positive or inconclusive Zika virus testAdditional hearing screen at 6 monthsAudiology follow-up for abnormal hearing screensHead circumference and developmental milestones through age 1 yearRefer for abnormalities (neurology, developmental pediatrics, physical or speech therapy)No known abnormalities from Zika acquired around time of delivery
Slide19What about breastfeeding?
Zika virus RNA has been found in breastmilkNo reported cases of transmission through breastfeedingBenefits outweigh “theoretical” risk of transmissionCDC encourages infected mothers and mothers in endemic areas to breastfeed
Slide20What about sexual transmission?
Zika virus detected in semen up to 62 days after symptom onsetNot detected in vaginal swabsIn men with clinical illness, transmission occurred before, during, and after symptomatic periodCondoms or abstinence x 6 monthsMen diagnosed with ZikaPossibly exposed male partners of pregnant women (travel to affected area)
Slide21Slide22References
Testing:
Centers for Disease Control and Prevention. Memorandum, CDC Division of Vector-Borne Diseases: Revised diagnostic testing for
Zika
, chikungunya, and dengue viruses in US Public Health Laboratories. Available at:
http://www.cdc.gov/zika/pdfs/denvchikvzikv-testing-algorithm.pdf
. Accessed September 22,
2016.